Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
05/2010
05/12/2010CN101703545A Ginkgo American ginseng saponin capsule and preparation method thereof
05/12/2010CN101703544A Pellet of acanthopanax senticosus extract and preparation method thereof
05/12/2010CN101703524A Quality control method for leech and preparation containing leech
05/12/2010CN101703519A Method for improving hemostatic effect of external-use zeolite hemostat by calcium ion modification
05/12/2010CN101703513A Compound sustained-release preparation of aspirin and clopidogrel or pharmaceutically acceptable salt thereof
05/12/2010CN101703497A Application of Chlorogenic acid in preparing drug having protection and restoration functions on spleen hematopoietic stem cell injuries
05/12/2010CN101703493A Electrospinning composite nanofiber membrane of medicament ferulic acid, preparation method and application thereof
05/12/2010CN101703475A Chondroitin sulfate pellet and preparation method thereof
05/12/2010CN101703240A Plasmin carrier lipidosome for promoting absorption of intestine and preparation method thereof
05/12/2010CN101703178A Method for removing gingkolic acid from gingkgo by adopting food engineering technology
05/12/2010CN101342267B Donkey-hide gelatin angelica polymorpha & hoantchy particle and method of preparing the same
05/12/2010CN101190915B Anti-thrombus N-butyl-2,2-dimethyl-4-oxy-tetrahydroimidazopyridoindole and its synthesis and application
05/12/2010CN101190297B Traditional Chinese medicine compound preparations for preventing and controlling abnormal uterine bleeding after medical abortion
05/12/2010CN101073597B Medicinal composition for contracting uterus, stopping blood and regulating emmenia and its production method
05/12/2010CN101072506B Methods for preparing freeze-dried platelets, compositions comprising freeze-dried platelets, and methods of use
05/12/2010CN101062086B Composite medicine for reducing blood fat and dissolving thrombus and its preparing process
05/12/2010CN101049356B Pharmaceutical composition of containing puerarin and leaves of hawthorn
05/12/2010CN101032512B Medicine composition for expanding blood volume and the preparing method thereof
05/12/2010CN101011421B Pollen tablet and its preparing process
05/12/2010CN100998638B Traditional Chinese medicine for nourishing liver and kidney, nourishing blood and invigorating the circulation of blood
05/12/2010CN100998617B Quality control method for Xindakang preparation
05/11/2010US7713999 Thrombin receptor antagonists
05/11/2010US7713963 Acylated indanyl amines and their use as pharmaceuticals
05/11/2010US7713721 Methods and composition for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs
05/11/2010US7713514 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
05/11/2010CA2438260C Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects
05/11/2010CA2412968C Substituted pyridines as selective cyclooxygenase-2 inhibitors
05/11/2010CA2410177C Thrombin receptor antagonists
05/11/2010CA2381205C Method for determining physiological effects of hemoglobin
05/11/2010CA2326401C Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
05/06/2010WO2010050787A2 Encapsulated functional fine particle composition capable of spraying and preparation method thereof
05/06/2010WO2010050525A1 Compound having tafia inhibitory activity
05/06/2010WO2010050168A1 Solid solution of valine, isoleucine and leucine, and method for producing same
05/06/2010WO2010049709A2 Therapeutic compositions
05/06/2010WO2010049705A2 Therapeutic compositions
05/06/2010US20100115638 Method for inhibiting the expression of endogenous erythropoietin (epo)
05/06/2010US20100113506 Composition for preventing or treating thrombus- or embolus- associated disease
05/06/2010US20100113488 Macrocyclic factor viia inhibitors useful as anticoagulants
05/06/2010US20100113444 Prolyl hydroxylase inhibitors
05/06/2010US20100113393 Boronic Acid Salts
05/06/2010US20100113391 Bicyclic heterocyclic compound
05/06/2010US20100113388 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
05/06/2010US20100113365 Factor viii polymer conjugates
05/06/2010US20100113364 Factor viii polymer conjugates
05/06/2010US20100113360 Parathyroid hormone receptor activation and stem and progenitor cell expansion
05/06/2010US20100113353 Method and composition for inhibiting cardiovascular cell proliferation
05/06/2010US20100113345 Preparation of low bleeding anticoagulant fusion protein and its use
05/06/2010US20100113339 Serum albumin binding proteins with long half-lives
05/06/2010US20100111946 Inhibiting activation with human anti-factor c3 antibodies and use thereof
05/06/2010US20100111910 Treatment of excessive neovascularization
05/06/2010US20100111898 Conjoint therapy for treating fibrotic diseases
05/06/2010CA2741783A1 Compounds having tafia inhibitory activity
05/05/2010EP2181731A1 Organic compounds with biological effect as thrombin inhibitor and use of same
05/05/2010EP1485100B1 Azinylaminoazoles as inhibitors of protein kinases
05/05/2010EP1414486B1 Use of glp-2 in combination with another therapeutic agent in bone-related disorders
05/05/2010EP0946185B2 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
05/05/2010CN1981853B Chinese-medicinal decoction for treating heart disease and cerebral thrombosis and its making method
05/05/2010CN1981840B Chinese-medicinal composition with anti-inflammatory and hemostasis functions and its production
05/05/2010CN1964729B Composition for prevention and treatment of urinary incontinence
05/05/2010CN1961912B Chinese medicinal composition having pain-easing bleeding-stopping functions
05/05/2010CN1954812B Use of Edaravone
05/05/2010CN1911219B Medicine composition, and its application
05/05/2010CN1883493B Solid-state molecular dispersible preparation of pennogenin compound
05/05/2010CN1816353B Medicinal composition for preventing or treating Th1 type immunological disease
05/05/2010CN1682707B Pharmaceutical composition comprising fenofibrate and process for its preparation
05/05/2010CN1665496B Use of EPA and DHA in Preparation of medicinie for secondary prevention of neurogenic diseases
05/05/2010CN1642574B Remedies for glomerular diseases
05/05/2010CN101701020A Amide derivate, preparation method and application thereof
05/05/2010CN101700364A Thrombolytic and lipid-lowering pill
05/05/2010CN101700341A Biological composition for nourishing kidney and protecting liver and preparation method for oral liquid thereof
05/05/2010CN101700326A Preparation method of traditional Chinese medicine preparation for clearing heat and promoting urination for treating stranguria
05/05/2010CN101700285A Application of rumex japonicus in preparing medicines
05/05/2010CN101700267A Detection method of persimmon leaf quality
05/05/2010CN101700251A Donkey-hide gelatin soft capsule
05/05/2010CN101700248A Preparation method of Aspirin and Captopril enteric sustained-release capsule
05/05/2010CN101700243A Novel medicine carrying woundplast with treating function
05/05/2010CN101700228A Preparation method of amino polysaccharide Aspirin composite nanometer particles
05/04/2010US7709677 e.g.3-{3-[(2-{[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}ethyl)amino]phenyl}isonicotinic acid ; useful as agonists at atypical beta-adrenoceptors; treatment of hyperglycaemia, animal growth promoters, blood platelet aggregation inhibitors, as positive inotropic agents and antiatherosclerotic agent
05/04/2010US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia
05/04/2010US7709515 Therapy for cardiovascular disorders; dyslipidemia; glucose metabolism disorders; Alzheimer's disease
05/04/2010US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis
05/04/2010US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents
05/04/2010US7709500 Chemical compounds
05/04/2010US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
05/04/2010US7709463 Methyl O-(2,3,4-tri-O-methyl-6-O-sulfo- alpha -D-glucopyranosyl)-(1 --> 4)-O-(2,3-di-O-methyl- beta -D-glucopyranosyl uronic acid)-(1 --> 4)-O-(2,3,6-tri-O-sulfo- alpha -D-glucopyranosyl)-(1 --> 4)-O-(2,3-di-O-methyl- alpha -L-idopyranosyl uronic acid)-(1 --> )-2,3,6-tri-O-sulfo- alpha -D-glucopyranoside
05/04/2010US7709461 Administering an aerosol of dry polysaccharide such as heparin of given particle size diameter
05/04/2010US7709460 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality
05/04/2010US7709255 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells
05/04/2010US7709220 Methods of monitoring treatment of BAFF-R related disease
05/04/2010US7708987 ras-mediated; administering immunosuppressive for immune constituents that may interfere with the systemic delivery of the reovirus; antiproliferative; in the neoplastic cells phosphorylation of PKR is prevented by inactivation or deletion of PKR; antitumor agents
05/04/2010CA2462456C Androstane 17-beta-carboxamides as androgen receptor modulators
05/04/2010CA2440419C Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors.
05/04/2010CA2437767C Heterocyclic inhibitors of erk2 and uses thereof
05/04/2010CA2427608C Condensed pyradizindione derivatives as pde inhibitors
05/04/2010CA2221568C Metabolic effects of certain glutathione analogs
04/2010
04/29/2010WO2010047756A1 Oral dosage forms including an antiplatelet agents and an enterically coated acid inhibitor
04/29/2010US20100105896 Pharmaceutical compounds
04/29/2010US20100105757 Treatment and inhibition of disease conditions using flexible heteroarotinoids
04/29/2010US20100105731 Novel benzamidine compound
04/29/2010US20100105712 Chemical compounds